Myriad Genetics Inc (NASDAQ:MYGN)

34.60
Delayed Data
As of May 22
 +0.13 / +0.38%
Today’s Change
31.56
Today|||52-Week Range
40.50
+1.59%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Evans James S
Chief Financial Officer
Sale9/23/201475,864$38.08$2.9M-8.66%
Evans James S
Chief Financial Officer
Buy9/23/201475,864$30.12$2.3M-8.66%
Meldrum Peter D
President & Chief Executive Officer
Sale7/14/201424,000$39.50$948.0K-14.38%
Lanchbury Jerry S
Chief Scientific Officer
Sale7/14/201420,000$39.85$797.0K-14.38%
Evans James S
Chief Financial Officer
Sale9/30/201416,872$38.99$657.8K-10.29%
Evans James S
Chief Financial Officer
Sale9/19/201413,128$37.51$492.4K-7.76%
Lanchbury Jerry S
Chief Scientific Officer
Buy7/14/201420,000$18.06$361.2K-14.38%
Evans James S
Chief Financial Officer
Sale9/24/20148,790$37.98$333.8K-9.87%
Evans James S
Chief Financial Officer
Buy9/24/20148,790$30.12$264.8K-9.87%
King Gary A /myriad/
Executive Vice President
Sale11/03/20146,568$39.95$262.4K-12.36%
Page of 6

To view my watchlist

Not a member yet?

Sign up now for a free account